You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Evaluation of therapeutic efficacy and safety of novel small RNA target delivery platform in vivo.

    SBC: Oncoimmune Inc            Topic: 100

    Project Summary AbstractThe recent rapid expansion of genomic data greatly contributes to the understanding of disease development and progressionTo translate these genetic discoveries into clinical applicationswe need to develop therapeutic platforms that can specifically modulate the expression of disease related genes in vivoSmall RNAssuch as microRNAs and siRNAs function in messenger RNA silen ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. An Advanced Lung Organomimetic to Reproduce Human Airway Pathophysiology

    SBC: PNEUMAX, LLC            Topic: 113

    PROJECT SUMMARYThree of top five causes of death in humans globally are lung relatedchronic obstructive pulmonary diseaseCOPDlower respiratory infections and lung cancers collectively account for over eight million deaths annuallyCurrentlyin preclinical settingstatic cell cultures and animal models are the most widely used systems for mechanistic and translational studiesHowevercritical limitation ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. Design of Flexible Materials for Aerodynamic Structures

    SBC: ATREVIDA SCIENCE INC.            Topic: AF19BT001

    The PI has worked on a design concept for a wind turbine blade with adaptive twist transformation. The design improves wind capture and reduces loading on the system drivetrain turbine by adapting the twist distribution in relation to wind speed. Structural adaptability is enabled by actuating a series of compliant segments that are mounted on a relatively rigid spar. The segments are assumed to h ...

    STTR Phase I 2019 Department of DefenseAir Force
  4. Open Call for Science and Technology Created by Early-Stage (e.g. University) Teams

    SBC: OmniScience LLC            Topic: AF19BT001

    This proposed Phase I STTR effort will be a collaboration between OmniScience LLC and the University of Colorado Colorado Springs (UCCS) Vision and Security Technology (VAST) Lab. The primary objective of this Phase I effort is to demonstrate feasibility of a brain computer interface (BCI) controller for augmented/virtual reality (AR/VR) and conventional screen displays, referred to herein as an A ...

    STTR Phase I 2019 Department of DefenseAir Force
  5. Integrated Quantum Systems Design and Fabrication Technology

    SBC: Guided Particle Systems Inc.            Topic: AF19BT001

    Our proposal is focused on determining the need and feasibility for integrated quantum systems design and fabrication technologies to enable rapid research and development prototyping, and subsequent production, and an industrial base for integrated quantum machines and systems. We focus on the problem of field-able quantum systems for communication networks to support the Air Force as a use case ...

    STTR Phase I 2019 Department of DefenseAir Force
  6. Open Call for Science and Technology Created by Early-Stage (e.g. University) Teams

    SBC: GHOSTWAVE INC            Topic: AF19BT001

    The proliferation and capabilities of hobbyist off-the-shelf drone systems poses a direct and immediate threat to U.S. national security. This proposal is a cUAS system to track unwanted UAS in the vicinity using stealthy radars that are AJ. The project will start with an understanding of customer needs and how we can adapt our proposal to best meet the needs of the Air Force.

    STTR Phase I 2019 Department of DefenseAir Force
  7. Open Call for Science and Technology Created by Early-Stage (e.g. University) Teams

    SBC: KAIROS RESEARCH LLC            Topic: AF19BT001

    Assess the feasibility of a novel technology which automatically generates human-understandable explanations of an artificial intelligence (AI) algorithm’s decisions – for example, a deep neural network’s (DNN’s) classification decisions. Our technology, called EMERALD (Explainable Machine Reasoning through the Application of Linked Data), is designed to improve trust a ...

    STTR Phase I 2019 Department of DefenseAir Force
  8. Ubihere Air Force Focus Area Identified- Open Call for Science and Technology Created by Early-Stage (e.g. University) Teams

    SBC: UBIHERE, INC.            Topic: AF19BT001

    UbiHere, a Columbus Ohio based small business, has developed, in conjunction with The Ohio State University, a unique highly capable low-cost system to address the known issues with GPS denied tracking of assets, equipment or people in indoor and outdoor operating environments. UbiHere’s commercial system is comprised of an application specific electronics tag, designed by the company, whic ...

    STTR Phase I 2019 Department of DefenseAir Force
  9. Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke.

    SBC: BIOMIMETIX JV LLC            Topic: 102

    Ischemic stroke is a leading cause of death and disability in the United States. This often is attributable to thrombus formation at an atherosclerotic plaque or thromboembolism. Patients who present within 4.5 hours of symptom onset are eligible for thrombolysis with tissue plasminogen activator (tPA). This serves andlt;5% of victims. Recently, major advance has been made with proven efficacy fro ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting neurotoxic alpha-synuclein aggregates for Parkinson's disease therapy.

    SBC: Vova Ida, LLC            Topic: 999

    SUMMARYParkinsonandapos s diseasePDis the second most prevalent neurodegenerative disorder after Alzheimerandapos s diseaseADaffecting more thanmillion people in the United StatesBecause age is the major risk factorthe prevalence of both diseases is steadily increasing as our population agesPD belongs to the group of protein misfolding neurodegenerative diseases that are due to the misfolding and ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government